Back
Editas Medicine, Inc. Vs. Argan, Inc. Industry Stock Comparison
Sell
16
EDIT
Editas Medicine, Inc.
Last Price:
$2.21
Seasonality Move:
-10.7%
Buy
67
AGX
Argan, Inc.
Last Price:
$328.51
Seasonality Move:
5.53%
Sell
16
Editas Medicine, Inc. (EDIT)
is a Sell
Is Editas Medicine, Inc. a Buy, Sell or Hold?
-
The current Editas Medicine, Inc. [EDIT] share price is $2.21. The Score for EDIT is 16, which is 68% below its historic median score of 50, and infers higher risk than normal.
-
EDIT is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing an extreme reading that indicates risk could be especially high.
Buy
67
Argan, Inc. (AGX)
is a Buy
Is Argan, Inc. a Buy, Sell or Hold?
-
The current Argan, Inc. [AGX] share price is $328.26. The Score for AGX is 67, which is 34% above its historic median score of 50, and infers lower risk than normal.
-
AGX is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
EDIT Stock Price Chart
What is Editas Medicine, Inc.'s stock price today?
-
The Editas Medicine, Inc. share price today is $2.21Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and EDIT is experiencing slight buying pressure.
AGX Stock Price Chart
What is Argan, Inc.'s stock price today?
-
The Argan, Inc. share price today is $328.26The current trend is relatively stagnant and AGX is experiencing slight selling pressure.
EDIT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.07 | Sell |
| Relative Strength Index (14 RSI): | 36.53 | Sell |
| Chaikin Money Flow: | 100327 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (2.29 - 2.53) | Sell |
| Bollinger Bands (100): | (2.35 - 3.41) | Sell |
AGX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -2.06 | Sell |
| Relative Strength Index (14 RSI): | 49.53 | Sell |
| Chaikin Money Flow: | -12977 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (316.54 - 364.46) | Sell |
| Bollinger Bands (100): | (236.22 - 333.34) | Buy |
EDIT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 2.39 | Sell |
| 20-day SMA: | 2.39 | Sell |
| 50-day SMA: | 2.79 | Sell |
| 200-day SMA: | 2.37 | Sell |
| 8-day EMA: | 2.35 | Sell |
| 20-day EMA: | 2.43 | Sell |
| 50-day EMA: | 2.38 | Sell |
| 200-day EMA: | 1.27 | Buy |
AGX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 321.64 | Buy |
| 20-day SMA: | 335.99 | Sell |
| 50-day SMA: | 325.77 | Buy |
| 200-day SMA: | 232.93 | Buy |
| 8-day EMA: | 326.72 | Buy |
| 20-day EMA: | 329.97 | Sell |
| 50-day EMA: | 319.84 | Buy |
| 200-day EMA: | 247.96 | Buy |
Editas Medicine, Inc. Earnings Growth & EDIT Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.04 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.69 per share, and an increase next year of $0.89 per share.
Argan, Inc. Earnings Growth & AGX Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.31 per share, an increase next quarter of $0.14 per share, an increase this year of $2.73 per share, and an increase next year of $3.30 per share.
Editas Medicine, Inc. Technical Analysis
| Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 24 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | 24 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Argan, Inc. Technical Analysis
| Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | Dec 24 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||